Although our digital twin model predicts a strong anti-angiogenic effect of CAPE in ovarian cancer, available experimental data directly linking CAPE with modulation of the HIF-1α/VEGF-A axis in ovarian cancer remain lacking. This evidence concerns the gene VEGFA and ovarian carcinoma.